Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 34 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| RAPT Therapeutics, Inc. | 42,189 | reported | 25 May 2022 | tx 3+1,900−538,654 |
| Surrozen, Inc./DE | 5,550 | reported | 13 May 2026 | tx 35+2,757,922 |
| NGM BIOPHARMACEUTICALS INC | 0 | reported | 05 Apr 2024 | tx 35+581,952−21,743,413 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 May 2026 | GRANT_AWARD | Surrozen, Inc./DE | 5,550 | 0.00 USD | deriv |
| 15 Jan 2026 | PURCHASE | Surrozen, Inc./DE | 5,590 | 19.89 USD | |
| 15 Jan 2026 | PURCHASE | Surrozen, Inc./DE | 6,303 | 19.89 USD | |
| 20 Jan 2026 | PURCHASE | Surrozen, Inc./DE | 9,568 | 19.60 USD | |
| 16 Jan 2026 | PURCHASE | Surrozen, Inc./DE | 1,358 | 20.00 USD | |
| 20 Jan 2026 | PURCHASE | Surrozen, Inc./DE | 8,484 | 19.60 USD | |
| 16 Jan 2026 | PURCHASE | Surrozen, Inc./DE | 1,204 | 20.00 USD | |
| 14 Jan 2026 | PURCHASE | Surrozen, Inc./DE | 2,927 | 19.99 USD | |
| 14 Jan 2026 | PURCHASE | Surrozen, Inc./DE | 2,596 | 19.99 USD | |
| 13 Jan 2026 | PURCHASE | Surrozen, Inc./DE | 5,861 | 19.80 USD | |
| 13 Jan 2026 | PURCHASE | Surrozen, Inc./DE | 6,609 | 19.80 USD | |
| 06 Jan 2026 | PURCHASE | Surrozen, Inc./DE | 8,003 | 19.89 USD | |
| 06 Jan 2026 | PURCHASE | Surrozen, Inc./DE | 7,097 | 19.89 USD | |
| 05 Dec 2025 | PURCHASE | Surrozen, Inc./DE | 16,381 | 19.54 USD | |
| 04 Dec 2025 | PURCHASE | Surrozen, Inc./DE | 2,791 | 17.35 USD | |
| 04 Dec 2025 | PURCHASE | Surrozen, Inc./DE | 2,475 | 17.35 USD | |
| 05 Dec 2025 | PURCHASE | Surrozen, Inc./DE | 14,503 | 19.54 USD | |
| 13 Nov 2025 | PURCHASE | Surrozen, Inc./DE | 167,307 | 12.65 USD | first after silence |
| 13 Nov 2025 | PURCHASE | Surrozen, Inc./DE | 148,150 | 12.65 USD | |
| 26 Mar 2025 | GRANT_AWARD | Surrozen, Inc./DE | 2,666 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Surrozen, Inc./DE | 1,333 | 0.00 USD | deriv |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 949,862 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 2,650,177 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 90,442 | — | |
| 05 Apr 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 11,103,333 | — |
3 purchases reported after at least 12 months of silence — most recent on 13 Nov 2025.